the conditions of the host tissue receiving the PRP may account for the varied outcomes. The differential response among patients would suggest that PRP therapies could be directed in an individualized manner to treat specific subgroups of patients. Thus, personalized medicine may be applied to the field of PRPs. Revealing crucial facts underlying the success or the failure of PRP is a current challenge for PRP researchers. One could question the generalizability of PRP therapies, leading to an interpretation that the progression of tendinopathies and joint pathologies could be reduced, and even reversed, by PRP stimulation. High level of evidence studies are beginning to emerge and provide data for the management of tendon and osteoarticular conditions. Recently, a quantitative synthesis 3 and a meta-analysis 4 in knee joint cartilage degenerative pathology concluded that PRP tends to be more effective than HA administration, with patients with lower degrees of degeneration benefiting more. However, mostly symptomatology is evaluated, and so far MRI data evaluating OA progression are lacking. Similar circumstances affect tendinopathy. Constant re-evaluation to identify protocols that are likely to succeed is important for a rapid development on the field. PRP science is in its very beginning, and PRPs are used with limited mechanistic understanding of their molecular and cellular properties. Without knowledge concerning mechanisms of action, questions regarding dosage (platelet and leukocyte count and/or plasma volume), timing of delivery, and number of administrations are in its firsts. Thus, there is a clear need to stratify patients, and augment our knowledge by introducing novel approaches such as combination products, as well as procedural modifications tailored to every single condition: this may help to control cell activities for successful healing. Over the next few years, we hope to harness the full potential of PRP for managing musculoskeletal problems. For the time being, we have gathered under the same roof studies which promise to bridge this translational gap: enjoy.
